Holen Sie sich die Stockscreener-App
3.30
6.52%
-0.23
Handel nachbörslich:
3.29
-0.010
-0.30%
Schlusskurs vom Vortag:
$3.53
Offen:
$3.44
24-Stunden-Volumen:
19,491
Relative Volume:
0.52
Marktkapitalisierung:
$227.88M
Einnahmen:
$62.37M
Nettoeinkommen (Verlust:
$-78.98M
KGV:
-2.7049
EPS:
-1.22
Netto-Cashflow:
$-57.80M
1W Leistung:
-12.93%
1M Leistung:
-8.08%
6M Leistung:
-27.31%
1J Leistung:
-10.33%
1-Tages-Spanne:
$3.28
$3.4576
1-Wochen-Bereich:
$3.28
$3.99
52-Wochen-Spanne:
$2.70
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
Firmenname
Sophia Genetics Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SOPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| SOPH | 3.30 | 227.88M | 62.37M | -78.98M | -57.80M | -1.22 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Eingeleitet | BTIG Research | Buy |
| 2022-11-23 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-17 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten
SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com
SOPHiA GENETICS Reports Third Quarter 2024 Results - PR Newswire
3 Reasons Not to Give Up on Roku Stock - MSN
Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN
Cofle S.p.A. Enhances Share Buyback Strategy - MSN
Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? - MSN
Palantir, Trump Media Buzz Amid Investors Ahead Of Election Day - MSN
SOS Limited announces ADS ratio change - MSN
Exploring Sophia Genetics's Earnings Expectations - Benzinga
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.16% - MSN
IPO Roundup: Heritage Distilling, Transten Global and more - MSN
SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Insider Monkey
Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies - Nature.com
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Morgan Stanley Downgrades Biogen (BIIB) - MSN
The biggest U.S. homebuilder misses on earnings as it says buyers are staying on the sidelines - MSN
Clime Capital Announces Quotation of New Shares - MSN
SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - MarketBeat
US Penny Stocks To Watch In October 2024 - Simply Wall St
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine - AsiaOne
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 - Marketscreener.com
Millennium Management LLC Purchases 9,199 Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) - Defense World
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 22.8% in September - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Millennium Management LLC - MarketBeat
Artificial Intelligence (AI) in Precision Medicine Global Market Size, Trends 2024-2033 - WhaTech
The UAE Cerebrospinal Fluid Drainage Catheter Market Size & Outlook, 2030 - Grand View Research
Dynamic Advisor Solutions LLC Acquires 1,432 Shares of PepsiCo, Inc. (NASDAQ:PEP) - Defense World
Artificial Intelligence in Diagnostics Market to hit USD 7.3 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
What to Expect From Labcorp Holdings' Q3 2024 Earnings Report - MSN
SOPHiA GENETICS' SWOT analysis: data-driven medicine firm faces headwinds - Investing.com
Artificial Intelligence In Cancer Diagnostics Market Size, Industry Analysis, Key Insights And Forecast To ... - WhaTech
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 52.0% in September - Defense World
Federated Hermes Inc. Has $346,000 Stake in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Global Precision medicine software Market Expected to Reach $ 3112.52 Million by 2032, Growing at 11.4% CAGR - 대구포스트
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
The Agenda Setter: SOPHIE’s posthumous new album cements a pop visionary’s legacy - Dork Magazine
Sosandar – AGM Due On Thursday For Women’s Fashion Group Now Recovering Into Profits, Shares Now 10p, Brokers Predict 31p - UK Investor Magazine
Sophie's life was saved by a stranger. Some in her position have an 'unfair' disadvantage - SBS News
No luck for McDonald after another concussion setback - Albany Advertiser
‘My first impression was this person’s a genius’: the life and legacy of producer pioneer Sophie - The Guardian
Tracklist of SOPHIE's Posthumous Album Revealed - EDM.com
‘Extra proud’: Lions rookie reflects on AFLW rise - Sunshine Coast Daily
Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):